| Ytd | -1.65% | |
| 1y | -26.05% |
| Open | 2.98 | Prev Close | 2.94 | Low | 2.79 | High | 3.00 | Mkt Cap | 37.51M |
| Vol | 159.00 | Avg Vol | 237.85K | EPS | -1.45 | P/E | -2.03 | Forward P/E | -1.50 |
| Beta | 2.30 | Short Ratio | 4.74 | Inst. Own | 24.10% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-12 | 50-d Avg | 3.44 | 200-d Avg | 3.17 | 1yr Est | 20.50 |
Gainers Catheter Precision (AMEX:VTAK) shares moved upwards by 95.7% to $1.4 during Wednesday's
ZetaOmics introduces an autonomous "Computational Biologist" persona (agent) that performs r
Exon 21 L858R NSCLC Mutated Patients Treated Through Up to Six Cycles Reached 8.9-Month Median PFS;
In its written responses to Lantern's Type C meeting request, the FDA raised no objections to ke
Lantern Pharma (NASDAQ:LTRN) reported quarterly losses of $(0.30) per share which beat the analyst c
Lantern Pharma announced that it has entered into a definitive agreement for the purchase and sale o
For the first time, pharmaceutical scientists and medicinal chemists can access a unified, benchmark
The event follows the platform's scientific community debut at the American Association for Canc
Lantern Pharma Schedules Type C Meeting with the FDA to Advance HARMONIC™ Protocol Amendments Target
Lantern Pharma (NASDAQ:LTRN) reported quarterly losses of $(0.36) per share which beat the analyst c
Lantern Pharma shares rebound in premarket trading as the company debunks a false report regarding C
PMGC Holdings shares surged 100.6% to $3.35 in pre-market trading after announcing a licensing agree
The Planned Multicenter Phase 1 Trial Will Evaluate STAR-001 as Monotherapy and in Combination with
On Monday, 369 companies set new 52-week lows.
On Tuesday, 386 stocks made new 52-week lows.
During the session on Thursday, 461 stocks hit new 52-week lows.
On Thursday, 1076 companies hit new 52-week lows.
Companies Reporting Before The Bell • PG&E (NYSE:PCG) is likely to report quarterly earnings
Companies Reporting Before The Bell • Mastercard Inc. (NYSE:MA) is expected to report quarterly ear